387 related articles for article (PubMed ID: 20028429)
1. Dissociated expression of natural killer 1.1 and T-cell receptor by invariant natural killer T cells after interleukin-12 receptor and T-cell receptor signalling.
Emoto M; Shimizu T; Koike H; Yoshizawa I; Hurwitz R; Kaufmann SH; Emoto Y
Immunology; 2010 Jan; 129(1):62-74. PubMed ID: 20028429
[TBL] [Abstract][Full Text] [Related]
2. Reversible NK1.1 surface expression on invariant liver natural killer T cells during Listeria monocytogenes infection.
Emoto M; Yoshizawa I; Emoto Y; Takahashi Y; Hurwitz R; Miamoto M; Kaufmann SH
Microbes Infect; 2007; 9(14-15):1511-20. PubMed ID: 18024119
[TBL] [Abstract][Full Text] [Related]
3. Miscarriage induced by adoptive transfer of dendritic cells and invariant natural killer T cells into mice.
Negishi Y; Ichikawa T; Takeshita T; Takahashi H
Eur J Immunol; 2018 Jun; 48(6):937-949. PubMed ID: 29520760
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes.
Emoto Y; Yoshizawa I; Hurwitz R; Brinkmann V; Kaufmann SH; Emoto M
Microbes Infect; 2008 Mar; 10(3):224-32. PubMed ID: 18321748
[TBL] [Abstract][Full Text] [Related]
6. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
7. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
8. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
9. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer.
Wang Y; Bhave MS; Yagita H; Cardell SL
Front Immunol; 2020; 11():581301. PubMed ID: 33193386
[TBL] [Abstract][Full Text] [Related]
10. α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice.
Chen Q; Guo X; Deng N; Liu L; Chen S; Wang A; Li R; Huang Y; Ding X; Yu H; Hu S; Nie H
J Cell Mol Med; 2019 Feb; 23(2):1072-1085. PubMed ID: 30421497
[TBL] [Abstract][Full Text] [Related]
11. CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status.
Kulkarni RR; Villanueva AI; Read LR; Brisbin JT; Bhaumik SK; LaMarre J; Murali-Krishna K; Sharif S
Cell Tissue Res; 2017 Sep; 369(3):541-554. PubMed ID: 28550425
[TBL] [Abstract][Full Text] [Related]
12. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.
Michel ML; Keller AC; Paget C; Fujio M; Trottein F; Savage PB; Wong CH; Schneider E; Dy M; Leite-de-Moraes MC
J Exp Med; 2007 May; 204(5):995-1001. PubMed ID: 17470641
[TBL] [Abstract][Full Text] [Related]
13. Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
Hsu CY; Chueh YS; Kuo ML; Lee PT; Hsiao HS; Huang JL; Lin SJ
PLoS One; 2021; 16(12):e0261727. PubMed ID: 34936686
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
[TBL] [Abstract][Full Text] [Related]
15. α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice.
Ichikawa T; Negishi Y; Shimizu M; Takeshita T; Takahashi H
Eur J Immunol; 2016 Aug; 46(8):1867-77. PubMed ID: 27198610
[TBL] [Abstract][Full Text] [Related]
16. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
17. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
18. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
[TBL] [Abstract][Full Text] [Related]
19. TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.
Subleski JJ; Hall VL; Wolfe TB; Scarzello AJ; Weiss JM; Chan T; Hodge DL; Back TC; Ortaldo JR; Wiltrout RH
J Immunol; 2011 Jan; 186(2):838-47. PubMed ID: 21148802
[TBL] [Abstract][Full Text] [Related]
20. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
